MedTrace Logo

Tzanck Smear With Methylene Blue Stain for Herpes

NCT03178747 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2017-08-04

No results posted yet for this study

Summary

To compare the sensitivity of Tzanck smear with methylene blue stain versus traditional Giemsa stain in patients with herpes infection.

Conditions

  • Herpes Simplex
  • Herpes Zoster
  • Varicella Zoster

Interventions

DIAGNOSTIC_TEST

Methylene blue

working solution methylene blue

DIAGNOSTIC_TEST

Giemsa stain

working solution Giemsa stain (Wolbach's modification)

Sponsors & Collaborators

  • Dermatological Society of Thailand

    collaborator OTHER

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Pawinee Rerknimitr, MD, MSc · Chulalongkorn University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-07
Primary Completion
2017-12-07
Completion
2018-03-06

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03178747 on ClinicalTrials.gov